ebook img

Epilepsy in Children PDF

528 Pages·2002·10 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Epilepsy in Children

ARZIFM.QXD 10/24/03 9:59 AM Page i Aicardi’s Epilepsy in Children Third Edition ARZIFM.QXD 10/24/03 9:59 AM Page ii ARZIFM.QXD 10/24/03 9:59 AM Page iii Aicardi’s Epilepsy in Children Third Edition Alexis Arzimanoglou, M.D. Head, Pediatric Epilepsy Unit Department of Child Neurology and Metabolic Disorders and Institut National de la Santé et de la Recherche Médicale University Hospital Robert Debré Paris, France Renzo Guerrini, M.D. Professor of Child Neurology and Psychiatry Head of the Epilepsy, Neurophysiology and Neurogenetics Unit Department of Child Neurology and Psychiatry University of Pisa and Research Institute Stella Maris Foundation Pisa, Italy Jean Aicardi, M.D., F.R.C.P. Honorary Professor of Child Neurology Institute of Child Health, University College London; Research Director Institut National de la Santé et de la Recherche Médicale; Honorary Consultant Department of Child Neurology and Metabolic Disorders University Hospital Robert Debré Paris, France ARZIFM.QXD 10/24/03 9:59 AM Page iv Acquisitions Editor: Anne M. Sydor Developmental Editor: Jenny Kim Production Editor: Christiana Sahl Manufacturing Manager: Benjamin Rivera Cover Designer: Christine Jenny Compositor: Lippincott Williams & Wilkins Desktop Division Printer: Maple Press © 2004 by LIPPINCOTT WILLIAMS &WILKINS 530 Walnut Street Philadelphia,PA 19106USA LWW.com All rights reserved. This book is protected by copyright. No part of this book may be reproduced in any form or by any means, including photocopying, or utilized by any information storage and retrieval system without written permission from the copyright owner, except for brief quotations embodied in critical articles and reviews. Materials appearing in this book prepared by individuals as part of their official duties as U.S. government employees are not covered by the above-mentioned copyright. Printed in the USA Library of Congress Cataloging-in-Publication Data Arzimanoglou, A. Aicardi’s epilepsy in children / Alexis Arzimanoglou, Renzo Guerrini, Jean Aicardi.— 3rd ed. p. ; cm. Rev. ed. of: Epilepsy in children / Jean Aicardi. 2nd ed. c1994. Includes bibliographical references and index. ISBN 0-7817-2698-0 1. Epilepsy in children. I. Title: Epilepsy in children. II. Guerrini, Renzo. III. Aicardi, Jean. IV. Aicardi, Jean. Epilepsy in children. V. Title. [DNLM: 1. Epilepsy—classification—Child. 2. Epilepsy—classification—infant. 3. Epilepsy—diagnosis—Child. 4. Epilepsy—diagnosis—Infant. 5. Epilepsy—therapy— Child. 6. Epilepsy—therapy—Infant. WL 385 A797a2004] RJ496.E6A43 2004 618.92′853—dc22 2003054693 Care has been taken to confirm the accuracy of the information presented and to de- scribe generally accepted practices. However, the authors and publisher are not responsi- ble for errors or omissions or for any consequences from application of the information in this book and make no warranty, expressed or implied, with respect to the currency, com- pleteness, or accuracy of the contents of the publication. Application of this information in a particular situation remains the professional responsibility of the practitioner. The authors and publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accordance with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reac- tions, the reader is urged to check the package insert for each drug for any change in indi- cations and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new or infrequently employed drug. Some drugs and medical devices presented in this publication have Food and Drug Ad- ministration (FDA) clearance for limited use in restricted research settings. It is the re- sponsibility of the health care provider to ascertain the FDA status of each drug or device planned for use in their clinical practice. 10 9 8 7 6 5 4 3 2 1 ARZIFM.QXD 10/24/03 9:59 AM Page v Contents Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix Section I.General Aspects 1. Epilepsy: Overview and Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 2. Classification of Epileptic Seizures and Epilepsies . . . . . . . . . . . . . . . . . . . . . . . . 7 Section II. Major Types of Epileptic Seizures in Childhood and Corresponding Epileptic Syndromes 3. Infantile Spasms and Related Syndromes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 4. Lennox-Gastaut Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 5. Dravet Syndrome: Severe Myoclonic Epilepsy or Severe Polymorphic Epilepsy of Infants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51 6. Epilepsies with Predominantly Myoclonic Seizures . . . . . . . . . . . . . . . . . . . . . . . 58 7. Myoclonic Epilepsies Associated with Progressive Degenerative Disorders: Progressive Myoclonic Epilepsies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81 8. Epilepsies with Typical Absence Seizures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 9. Epilepsies with Tonic-Clonic Seizures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105 10. Epilepsies Characterized by Partial Seizures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114 11. Landau-Kleffner Syndrome and Syndrome of Continuous Spike-Waves of Slow Sleep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 176 Section III.Epileptic Manifestations Relative to Age,Cause,Duration, and Precipitation of Seizures 12. Neonatal Seizures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188 13. Epilepsy in Infants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210 14. Febrile Convulsions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220 15. Occasional Seizures Other Than Febrile Convulsions . . . . . . . . . . . . . . . . . . . . . . 235 16. Status Epilepticus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241 17. Stimulus-Sensitive Epilepsies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 262 18. Posttraumatic Seizures and Posttraumatic Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . 279 v ARZIFM.QXD 10/24/03 9:59 AM Page vi vi CONTENTS 19. Epilepsy as the Presenting Manifestation of Structural Brain Lesions . . . . . . . . . . 284 20. Genetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 312 Section IV.Selected Aspects of Diagnosis,Prognosis,and Treatment of Convulsive Disorders in Children 21. Diagnosis and Differential Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 325 22. General Aspects of Prognosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 342 23. General Principles of Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 354 24. Medical Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 363 25. Surgical Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 387 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 397 Subject Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 503 ARZIFM.QXD 10/24/03 9:59 AM Page vii Preface Since the second edition of this book, an enormous amount of new knowledge on epilepsy has accumulated at an increasing pace on both its basic and clinical aspects. Novel techniques of investigation and new forms of therapy, both medical and surgical, have been developed. Advances in genetics have clarified the etiology of some forms of monogenic epilepsy, and they may shortly provide some understanding of the more common syndromes with a multifactorial inheritance. Genetics have been shown to play a major role in some cases of ionic channel dysfunction. New concepts about the mechanisms of seizures and their propagation have led to the development of the concept of the epileptic network. New antiepileptic agents, some of which have been rationally rather than empirically devised, have been introduced as a result of the better knowledge of the mech- anisms of excitatory or inhibitory neurotransmission. Surgical treatment, which has benefitted immensely from the spectacular progress that has occurred in the techniques of structural and functional imaging, has be- come an established form of therapy, and new surgical methods such as stimulation are being tested. Such remarkable technical developments have evolved in parallel with the refinements in diagnostic capa- bilities, leading to the more precise delineation of epilepsy syndromes and to a better knowledge of their nat- ural history and sensitivity to drugs. The result has been the identification of more rational indications and con- traindications for the use of antiepileptic agents on a syndromic basis, as well as the better overall management of the patients. The realizations that epilepsy may consist of more than simply having seizures and that cogni- tive or behavioral abnormalities or both may result from infraclinical paroxysmal neuronal activity, such as oc- curs in the Landau-Kleffner syndrome or the syndrome of continuous spike-waves of sleep, emphasize some of the peculiar aspects of epilepsy in childhood. They underline the probable role of paroxysmal epileptic brain dysfunction on the development of the brain, possibly as a result of the plastic changes induced by the epilep- tic process. The incorporation of at least some of these recent findings while still retaining the clinical orientation of the book necessitated the development of a new edition. Collecting this mass of data and literature and re- viewing them in an accessible manner proved to be a formidable challenge beyond the abilities of a single au- thor, so a collective endeavor was required. The three authors of this edition have long shared a similar ap- proach to the study of epilepsy in children, as well as having considerable experience in its clinical diagnosis and management. We hope this common experience maintains the homogeneity of the text and avoids dis- crepancies. We have reviewed, discussed, and amended all chapters together in an effort to achieve a degree of coherence analogous to that of a single-authored book. The general structure of the book is the same as that of the previous two editions. The volume is divided into four parts. The first part discusses general notions about seizure disorders, including definitions of the ba- sic terms that are necessary to the understanding of the subsequent chapters, and the problems of classifica- tion of epileptic seizures and epilepsies. The second part describes the major types of epileptic seizures and the epilepsy syndromes in which the particular seizures are the major manifestation. For each type of seizure, an attempt has been made to delineate the associated syndromes and to assess the validity and usefulness of these syndromes for prognosis and treatment. This conforms with the clinical approach that uses the symptom as a starting point for reaching the most precise diagnosis possible. The third part deals with those epileptic mani- festations for which the age of occurrence or the precipitating factors are more informative than the clinical characteristics. General etiologies, both genetic and lesional, are also discussed in this section. The fourth part is concerned with the general aspects of diagnosis, prognosis, and treatment, while taking into account that the specific aspects of these problems are considered in the discussion of the individual syndromes. Jean Aicardi Alexis Arzimanoglou Renzo Guerrini vii ARZIFM.QXD 10/24/03 9:59 AM Page viii ARZIFM.QXD 10/24/03 9:59 AM Page ix Acknowledgments The authors thank the persons who directly or indirectly contributed to this book. Many of the opinions and ideas expressed here were discussed over the years with our faithful collaborators, Jean-Jacques Chevrie, Françoise Goutières, Edouard Hirsch, Philippe Kahane, and Lucio Parmeggiani. Their contribution to our un- derstanding of the many problems of epilepsy in children and their approach to dealing with them have been invaluable. This book is also a tribute to the memory of Professor Henri Gastaut and to Dr. Joseph Roger, pioneers in the field of epilepsy, whose examples have been a constant stimulation to us. Thanks are also due to Drs. Pierre Thomas, Françoise Salefranque, Jeanne Misès, and Perrine Plouin for their contributions to the illustrations. We also thank Brigitte Tricot, who, for the third time, did the considerable secretarial work for this text. In addition, we express our appreciation to the editorial team of Lippincott Williams & Wilkins, especially Anne Sydor, Jenny Kim, and Christiana Sahl for their support, help, and understanding. ix ARZIFM.QXD 10/24/03 9:59 AM Page x

Description:
Every physician who treats children with epilepsy will welcome this new Third Edition of Dr. Aicardi’s internationally acclaimed text. Now coauthored by three distinguished experts—Alexis Arzimanoglou, MD, Renzo Guerrini, MD, and Jean Aicardi, MD, FRCP—this edition has been completely revised
See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.